ECOLUMBER S.A. financials
ECOLUMBER S.A.
Country: ES Reporting currency: EUR Latest annual report: 2023-12-31
LEI:
959800XL1Q2FK0S18W48 Financial statements
(EUR, as reported — unscaled; 88 line items across 2 annual periods)
| Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | €23.0M | €18.3M |
| Cost of sales | €18.8M | €15.2M |
| Other income | €14.8K | €7.8K |
| Employee benefits expense | €2.0M | €1.7M |
| Depreciation & amortisation | €624.3K | €615.3K |
| Operating profit (EBIT) | -€5.6M | -€1.6M |
| Net finance income / (cost) | -€751.1K | -€534.3K |
| Finance costs | €628.0K | €430.0K |
| Profit before tax | -€13.9M | -€5.2M |
| Income tax expense | -€58.4K | -€189.6K |
| Profit for the year | -€13.8M | -€5.0M |
| — attributable to owners | -€13.8M | -€5.0M |
| Total comprehensive income | -€13.8M | -€5.0M |
| Cash flow statement | ||
| Net cash from operating activities | -€201.6K | -€1.9M |
| Net cash from investing activities | €209.2K | -€435.2K |
| Purchase of PP&E (capex) | €62.3K | €363.3K |
| Purchase of intangibles | €113.2K | €50.0K |
| Net cash from financing activities | €630.6K | €2.3M |
| Proceeds from borrowings | €1.2M | €3.7M |
| Repayments of borrowings | €553.9K | €1.4M |
| Balance sheet | ||
| Total assets | €17.7M | €30.9M |
| Non-current assets | €6.9M | €22.5M |
| Property, plant & equipment | €4.0M | €8.4M |
| Right-of-use assets | €75.2K | €847.0K |
| Intangible assets & goodwill | €2.2M | €6.2M |
| Current assets | €10.8M | €8.4M |
| Inventories | €3.2M | €4.0M |
| Trade & other receivables | €3.5M | €3.3M |
| Cash & equivalents | €1.1M | €506.3K |
| Total equity | -€5.8M | €8.1M |
| Non-current liabilities | €11.6M | €12.9M |
| Long-term borrowings | €10.7M | €11.9M |
| Current liabilities | €11.9M | €9.9M |
| Deferred tax liabilities | €718.6K | €775.0K |
| Derived metrics | ||
| Free cash flow | -€263.9K | -€2.2M |
| Operating margin | -24.3% | -8.8% |
| Net margin | -60.0% | -27.4% |
| Return on equity | 240.0% | -62.3% |
| Cash conversion ratio | 0.01× | 0.37× |
| Capex coverage | -3.24× | -5.15× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €677.0K | €279.0K |
| Adjustments For Decrease Increase In Other Current Assets | €102.0K | -€7.1K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€149.2K | -€803.5K |
| Adjustments For Depreciation and Amortisation Expense | €624.3K | €1.1M |
| Adjustments For Finance Costs | €628.0K | €494.7K |
| Adjustments For Finance Income | €19.9K | €6 |
| Adjustments For Gain Loss On Disposal of Investments In Subsidiaries Joint Ventures and Associates | -€3.3M | €0 |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -€3.4M | €265.3K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €3.9M | €2.0M |
| Adjustments For Increase Decrease In Other Current Liabilities | €0 | €578 |
| Adjustments For Increase Decrease In Trade and Other Payables | €1.1M | €675.7K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | €102.4K | -€173.3K |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | €12.2M | €3.5M |
| Cash Advances and Loans From Related Parties | €196.6K | €2.8M |
| Changes In Inventories of Finished Goods and Work In Progress | €56.9K | -€45.4K |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €8.1M | €7.0M |
| Current Financial Assets | €30.0K | €121.7K |
| Current Prepayments and Current Accrued Income Including Current Contract Assets | €62.6K | €72.9K |
| Deferred Tax Assets | €563.9K | €563.9K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €0 | €0 |
| Equity and Liabilities | €17.7M | €30.9M |
| Finance Income | €19.9K | €6 |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -€102.4K | €173.3K |
| Increase Decrease In Cash and Cash Equivalents | €638.1K | -€6.0K |
| Increase Decrease In Working Capital | -€1.7M | -€144.7K |
| Increase Decrease Through Other Distributions To Owners | €0 | — |
| Increase Decrease Through Transfers and Other Changes Equity | — | €90.0K |
| Interest Paid Classified As Operating Activities | €303.9K | €337.5K |
| Issued Capital | €15.9M | €15.9M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €2.9M | €384.0K |
| Noncurrent Biological Assets | €0 | €6.5M |
| Noncurrent Government Grants | €226.3K | €220.3K |
| Other Adjustments For Noncash Items | €128.2K | €161.3K |
| Other Comprehensive Income | €0 | €0 |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €0 | €0 |
| Other Expense By Nature | €3.3M | €2.3M |
| Other Gains Losses | €1.5K | €3.1K |
| Other Inflows Outflows of Cash Classified As Investing Activities | €0 | -€23.8K |
| Proceeds From Disposal of Noncurrent Assets Or Disposal Groups Classified As Held For Sale and Discontinued Operations | €384.0K | €0 |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €384.7K | €1.9K |
| Proceeds From Sales of Investments Other Than Investments Accounted For Using Equity Method | €717 | €0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €0 | €1.9K |
| Profit Loss From Continuing Operations | -€6.3M | -€2.0M |
| Profit Loss From Discontinued Operations | -€7.5M | -€3.1M |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €175.5K | €437.1K |
| Retained Earnings Profit Loss For Reporting Period | -€13.8M | -€5.0M |
| Share Premium | €143.8K | €143.8K |
| Treasury Shares | €480.5K | €480.5K |
Methodology
Every line item above is a fact tagged in ECOLUMBER S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.